United Therapeutics said the FDA has cleared it to begin the first clinical trial testing whether organs from gene-edited pigs could provide a viable option for human patients.
Genesis announced that it has completed its second successful human transplant with a genetically engineered pig kidney, with ...
Even without creating inheritable gene changes, however, xenotransplantation using CRISPR is in its infancy. For all the promise of the headlines, there is not yet one example of a stable ...
The hazards of xenotransplantation are influenced not only by the origin of the donor animal, but also by the type of cells and their processing. Cellular transplantation not only holds the ...
Unfortunately, xenotransplantation is a risky process because of the chance of tissue rejection. For example, a high profile pig heart transplantation from 2023 ended in tragedy: Lawrence Faucette ...
United Therapeutics Corp. announced Feb. 4. that it will start a trial in mid-2025 with six patients who have end-stage renal disease. These patients, who have been on dialysis for at least six months ...